These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16372532)

  • 21. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.
    Kalayda GV; Wagner CH; Buss I; Reedijk J; Jaehde U
    BMC Cancer; 2008 Jun; 8():175. PubMed ID: 18565219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
    Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
    Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-resistance to cisplatin in cells with acquired resistance to copper.
    Safaei R; Katano K; Samimi G; Naerdemann W; Stevenson JL; Rochdi M; Howell SB
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):239-46. PubMed ID: 14648017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.
    Katano K; Kondo A; Safaei R; Holzer A; Samimi G; Mishima M; Kuo YM; Rochdi M; Howell SB
    Cancer Res; 2002 Nov; 62(22):6559-65. PubMed ID: 12438251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.
    Safaei R; Howell SB
    Crit Rev Oncol Hematol; 2005 Jan; 53(1):13-23. PubMed ID: 15607932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
    Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
    Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.
    Matsuzaki S; Enomoto T; Serada S; Yoshino K; Nagamori S; Morimoto A; Yokoyama T; Kim A; Kimura T; Ueda Y; Fujita M; Fujimoto M; Kanai Y; Kimura T; Naka T
    Int J Cancer; 2014 Apr; 134(8):1796-809. PubMed ID: 24150977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.
    Ahmed Z; Deyama Y; Yoshimura Y; Suzuki K
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):643-50. PubMed ID: 18545997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A).
    Song L; Li Y; Li W; Wu S; Li Z
    J Cell Biochem; 2014 Jul; 115(7):1234-42. PubMed ID: 24038379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
    Howell SB; Safaei R; Larson CA; Sailor MJ
    Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
    Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lustrous insights into cisplatin accumulation: copper transporters.
    Kruh GD
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5807-9. PubMed ID: 14676099
    [No Abstract]   [Full Text] [Related]  

  • 33. Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells.
    Katano K; Safaei R; Samimi G; Holzer A; Tomioka M; Goodman M; Howell SB
    Clin Cancer Res; 2004 Jul; 10(13):4578-88. PubMed ID: 15240550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
    Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
    Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
    Buß I; Hamacher A; Sarin N; Kassack MU; Kalayda GV
    Metallomics; 2018 Mar; 10(3):414-425. PubMed ID: 29417972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.
    Liu JJ; Kim Y; Yan F; Ding Q; Ip V; Jong NN; Mercer JF; McKeage MJ
    Biochem Pharmacol; 2013 Jan; 85(2):207-15. PubMed ID: 23123662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
    Ekblad L; Kjellström J; Johnsson A
    Anticancer Drugs; 2010 Jun; 21(5):523-31. PubMed ID: 20168208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles and mechanisms of copper transporting ATPases in cancer pathogenesis.
    Zhang Y; Li M; Yao Q; Chen C
    Med Sci Monit; 2009 Jan; 15(1):RA1-5. PubMed ID: 19114980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human solid carcinomas.
    Katoh R; Takebayashi Y; Takenoshita S
    Ann Thorac Cardiovasc Surg; 2005 Jun; 11(3):143-5. PubMed ID: 16030471
    [No Abstract]   [Full Text] [Related]  

  • 40. Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.
    Nakayama K; Kanzaki A; Ogawa K; Miyazaki K; Neamati N; Takebayashi Y
    Int J Cancer; 2002 Oct; 101(5):488-95. PubMed ID: 12216079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.